CHB 0.00 Global X China Biotech Innovation ETF
Range: | 6.63-9.76 | Vol Avg: | 712 | Last Div: | 0.04 | Changes: | -0.03 |
Beta: | 0.66 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
Sector: | | IPO: | Fri Sep 25 2020 | Empoloyees: | |
CUSIP: | 37954Y251 | CIK: | 0001432353 | ISIN: | US37954Y2515 | Country: | US |
|
The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China’s biotechnology industry. It is non-diversified.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.